Puromycin is an aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome. Among its listed roles, it functions as a nucleoside antibiotic, an antiinfective agent, an antineoplastic agent, a protein synthesis inhibitor, an antimicrobial agent, an EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor and an EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor. It is the conjugate base of puromycin(1+). It is grouped under the following drug class(es): Trypanosomiasis agents. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include 3′-(L-alpha-Amino-p-methoxyhydrocinnamamido)-3′-deoxy-N, N-dimethyladenosine, 3′-deoxy-N and N-dimethyl-3′-(O-methyl-L-tyrosinamido)adenosine. Its PubChem CID is 439530.
Puromycin
| CAS No | 53-79-2 |
|---|---|
| Molecular Formula | C22H29N7O5 |
| Molecular Weight | 471.5 g/mol |
| Synonyms | (2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Puromycin is an aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome.
The listed CAS number is 53-79-2.
The listed molecular formula is C22H29N7O5.
The listed molecular weight is 471.5 g/mol.
(2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide.
The source lists 3'-(L-alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N, N-dimethyladenosine, 3'-deoxy-N and N-dimethyl-3'-(O-methyl-L-tyrosinamido)adenosine.